VRTX FY 2022 Earnings — Vertex Pharmaceuticals Incorporated Revenue & Financial Results | Market Cap Arena

VRTXVertex Pharmaceuticals Incorporated

$129B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8.9B+17.9% YoY

Gross Profit

$7.9B87.9% margin

Operating Income

$4.3B48.2% margin

Net Income

$3.3B37.2% margin

EPS (Diluted)

$12.82

Cash Flow

Operating Cash Flow

$4.1B

Free Cash Flow

$3.9B

Stock-Based Comp.

$491M

Balance Sheet

Total Assets

$18.2B

Total Liabilities

$4.2B

Stockholders' Equity

$13.9B

Cash & Equivalents

$10.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8.9B	$7.6B	+17.9%
Gross Profit	$7.9B	$6.7B	+17.7%
Operating Income	$4.3B	$2.8B	+54.8%
Net Income	$3.3B	$2.3B	+41.8%